Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Single-administration vaccines: controlled-release technology to mimic repeated immunizations.

J L Cleland1

  • 1Pharmaceutical R&D, Genentech, South San Francisco, CA 94080, USA. cleland@gene.com

Trends in Biotechnology
|March 31, 1999
PubMed
Summary

Single-administration vaccines use controlled-release microspheres to deliver antigens over time. This technology aims to provide complete disease protection with just one injection, eliminating the need for repeat doses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A slow release formulation of insulin as a treatment for osteoarthritis.

Osteoarthritis and cartilage·2002
Same author

Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres.

Journal of pharmaceutical sciences·2001
Same author

Comparison of the rates of deamidation, diketopiperazine formation and oxidation in recombinant human vascular endothelial growth factor and model peptides.

AAPS pharmSci·2001
Same author

Comparison between light induced and chemically induced oxidation of rhVEGF.

Pharmaceutical research·2001
Same author

Partial molar volume, surface area, and hydration changes for equilibrium unfolding and formation of aggregation transition state: high-pressure and cosolute studies on recombinant human IFN-gamma.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis.

Journal of controlled release : official journal of the Controlled Release Society·2001

Area of Science:

  • Biomedical Engineering
  • Vaccinology
  • Materials Science

Background:

  • Vaccinations are crucial for disease elimination but often require multiple doses.
  • Repeated vaccine administration poses logistical and compliance challenges.

Purpose of the Study:

  • To develop single-administration vaccine formulations using controlled-release technology.
  • To achieve sustained antigen release for prolonged immune stimulation.

Main Methods:

  • Development of injectable microspheres encapsulating vaccine antigens.
  • Utilizing biodegradable polymers whose degradation rate controls antigen release.
  • Investigating the impact of polymer composition and molecular weight on release kinetics.

Main Results:

Related Experiment Videos

  • Microsphere formulations enable pulsed antigen release 1-6 months post-injection.
  • Release timing is tunable by adjusting polymer properties.
  • This approach offers a potential solution for single-dose vaccination.

Conclusions:

  • Controlled-release microspheres represent a promising strategy for single-administration vaccines.
  • This technology can automate repeated antigen exposure, enhancing vaccine efficacy and compliance.
  • Further development may lead to complete disease protection from a single injection.